National Science Foundation RII Track-1 Project:Expanding Research, Education and Innovation in South Dakota
SD EPSCoR News
December 11, 2018
- Department of Commerce (DoC)
- Department of Defense (DoD)
- Department of Energy (DoE)
- Health and Human Services (HHS)
- National Aeronautics and Space Administration (NASA)
- National Science Foundation (NSF)
- United States Agency for International Development (USAID)
- United States Department of Agriculture (USDA)
Department of Commerce (DoC)
Department of Defense (DoD)
Department of Energy (DoE)
Health and Human Services (HHS)
- Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Not Allowed)
- U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)
- CDC’s Collaboration with Academia to Strengthen Public Health Workforce Capacity
- FIELD INITIATED PROJECTS PROGRAM (DEVELOPMENT)
- Improving Detection and Management of Glaucoma and Other Eye Diseases Among High Risk Populations
- Research Approaches to Improve the Care and Outcomes of People Living with Spina Bifida
- The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
- HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
- HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
- HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
- HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 – Clinical Trial Optional)
- HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 – Clinical Trial Optional)
- HEAL Initiative: Early Phase Pain Investigation Clinical Network – Specialized Clinical Centers (U24 Clinical Trial Not Allowed)
- HEAL Initiative Limited Competition: Behavioral Research to Improve MAT: Ancillary Studies to Enhance Behavioral or Social Interventions to Improve Adherence to Medication Assisted Treatment for Opioid Use Disorders (R01, Clinical Trials Optional)